Language selection

Search

Top of page

Bed-Rest and Isolation Studies 2014

Announcement of Opportunity

Publication date: October 7, 2014

Application deadline: December 8, 2014

Table of Contents

  1. Introduction
  2. AO Objectives
  3. Eligibility Criteria
  4. Applications
  5. Evaluation
  6. Funding
  7. Funding Agreements
  8. Privacy Notice Statement
  9. Frequently Asked Questions (FAQ)

Eligible Projects:

Projects eligible for funding in the present solicitation process are those where Canadian researchers are involved as principal investigator or as co-investigator, and that have been selected based on scientific merit and feasibility through one of the following European Space Agency (ESA) Announcement of Opportunities:

  • Life Science Research Using the Spaceflight Analogue "Bed Rest" (AO-13-BR)
  • Call for Medical, Physiological and Psychological Research Using Concordia Antarctic Station as Human Exploration Analogue (AO-13-Concordia)

Funding available and Maximum Timeframe of the Project

The total financing amount given in grant for this AO is $1.5 million for a maximum period of three years. It is expected that Funding for bed-rest initiatives will cover a maximum period of two years, and a maximum of three years for studies conducted at the Concordia Antarctic Station. The overall number of grants awarded and their level will depend on budget requested by each proposal and the availability of funds.

The Canadian Space Agency (CSA) reserves the right not to accept any proposals or to reduce the amount of the grant requested at its entire discretion.

1. Introduction

In the future, human exploration of space is expected to extend beyond Low Earth Orbit (LEO) to targets such as Mars or near-Earth objects. The resulting expeditions will require extended periods of exposure to weightlessness and space radiation, with confinement and isolation in the extreme environment of space, all of which are linked to substantial health and performance risks.

The CSA is interested in human spaceflight and maintaining a healthy and highly qualified Canadian astronaut corps capable of participating in space exploration missions. To achieve this, the CSA's Health and Life Sciences (HLS) group conducts activities generating knowledge in fields that sustain human space flights, mitigate health risks and develop countermeasures for those missions. Bed-rest and isolation studies are spaceflight analogues that are valuable for initial validation of new countermeasures and for improving understanding of risks of spaceflight.

Through the CSA's participation in the European Life and Physical Sciences Program (ELIPS-4), Canadian investigators have access to space analogue facilities such as bed rest that are not available in Canada. In October 2013, the ESA released two Announcements of opportunity (AOs) to which Canadian investigators could submit proposals: Life Science Research Using the Spaceflight Analogue "Bed Rest" (AO-13-BR); and Medical, Physiological and Psychological Research Using Concordia Antarctic Station as Human Exploration Analogue (AO-13-Concordia).

Previous bed-rest studies have been direct precursors of Canadian experiments on the International Space Station (ISS), and isolation studies allow for medical, physiological, and psychological research in Isolated and Confined Environments (ICEs) resembling space. The ESA AOs have closed and ESA has completed its review process, resulting in a selection of the experiments that will be part of future bed-rest campaigns and isolation studies.

In order to achieve its program objectives, the CSA HLS group is launching this AO to solicit proposals for funding from investigators who have applied to either the ESA AO for Life Science Research Using the Spaceflight Analogue "Bed Rest" (AO-13-BR) or the ESA Call for Medical, Physiological and Psychological Research Using Concordia Antarctic Station as Human Exploration Analogue (AO-13-Concordia), and have been selected by ESA to participate in their bed-rest studies or their Concordia Antarctic Station research opportunities. In other words, this CSA AO is only open to Canadian researchers whose proposal to ESA in one of the two aforementioned ESA AOs has passed the ESA peer and technical reviews. This CSA AO will lead to funding of the Canadian members of the science teams; infrastructure costs for the bed-rest or isolation campaigns are paid by ESA.

Please read the following AO thoroughly before submitting your application. It has been prepared to assist applicants through the application process, and it outlines important elements including mandatory criteria for eligibility, details on eligible projects and the selection process. In the event of any discrepancies between this AO and the individual funding agreements governing a project(s), the latter document(s) will take precedence.

This AO is consistent with the terms and conditions of the CSA Class Grant and Contribution Program to Support Research, Awareness and Learning in Space Science and Technology – Research Component described on the following page: www.asc-csa.gc.ca/eng/funding-programs/grants-and-contributions-snapshot.asp.

2. AO Objectives

Through this AO, the CSA is seeking to financially support Canadian researchers involved in scientific experiments who have been selected by ESA in either the ESA AO for Life Science Research Using the Spaceflight Analogue "Bed Rest" (AO-13-BR) or the ESA Call for Medical, Physiological and Psychological Research Using Concordia Antarctic Station as Human Exploration Analogue (AO-13-Concordia), to be conducted during one of their bed-rest campaigns or Concordia Antarctic Station research opportunities. No other proposals will be considered for this CSA AO.

Projects selected from this CSA competition will have as their objective to increase the medical, physiological and/or psychological scientific knowledge that will contribute to the efforts toward the understanding, mitigation or elimination of health risks associated with human space exploration and generate scientific insights that will also contribute to applications on Earth.

More specifically, through this AO, the CSA seeks to:

The total financing amount given in grant for this AO is $1.5 million for a maximum period of three years. It is expected that funding for bed-rest initiatives will cover a maximum period of two years, and a maximum of three years for studies conducted at the Concordia Antarctic Station. The overall number of grants awarded and their level will depend on the budget requested by each proposal and the availability of funds. Proposals will be ranked on the basis of scores obtained in this CSA competition, based on evaluation criteria described in Section 5. The CSA reserves the right not to accept any proposals or to reduce the amount of the grant requested at its entire discretion.

3. Eligibility Criteria

3.1 Eligible Recipients

Eligible recipients (beneficiaries) for grants will be:

3.2 Eligible Projects

Projects eligible for funding in this solicitation process are those where Canadian researchers are involved as principal investigator or as co-investigator, and that have been selected based on scientific merit and feasibility through one of the following ESA AOs:

These projects will be performed during an ESA bed-rest campaign or a Concordia Antarctic Isolation Study and must be aligned with the CSA priorities identified in Sections 3.3 and 3.4 of this document.

A project may consist of several activities to attain its objectives or results. Any logical breakdown or combination of these activities can constitute a funded project. However, breaking down a project into numerous activities or sub-activities to obtain more than the maximum grant or contribution funding is not allowed for what is considered to be one project. Furthermore, even if the maximum funding for one project is not reached, the completion of a funded activity does not automatically guarantee funding of the remaining activities of the project. Details of eligible costs of the projects financed under this AO are listed in Section 6.

3.3 Links to CSA Priorities

To be eligible, projects supported under this AO must be aligned with CSA priority outcomes, as stated in the 2014–15 Report on Plans and Priorities. At the highest level, the contribution of Space Exploration "fosters the generation of knowledge as well as technological spin-offs that contribute to a higher quality of life for Canadians." As the CSA continues to collaborate in the European Life and Physical Sciences Program (ELIPS), Canadians have access to space analogue facilities such as bed rest that are not available in Canada. The HLS group of the CSA is sponsoring this AO and will only consider relevant those activities that are aligned with its mandate to "identify, understand, mitigate or eliminate health risks associated with human space flights, and to understand and address the needs of humans during those missions." The most important health risks associated with human space flights (i.e. future long-duration human spaceflight missions) have been identified and are listed in Table 3.1. Proposals that address one or more of the risks listed in this table will be given higher priority for CSA support.

The following table presents the human space flight risks targeted by the CSA for this AO.

Table 3.1. Eligible Human Space Flight Risks
Risk Category Description
Behavioural Health and Performance Short- and long-term behavioural health and performance risks, for example, associated with stress, issues with team dynamics.
Physiology

Research areas relevant for the study of physiological risks of human spaceflight:

  • Integrative physiology
  • Bone
  • Muscle
  • Nutrition and metabolism
  • Neurology
  • Cardio-vascular system
  • Rehabilitation medicine
  • Pharmacology
  • Gastro-intestinal, splenic, renal, hepatic, and pancreatic function
  • Immunology
  • Endocrinology
  • Physiological adaptation
  • Acute and chronic stress effects
  • Chronic and acute high-altitude physiology
  • Physiological countermeasures
  • Sleep & circadian rhythms

3.4 Links to G&C Program Objectives

To be eligible, projects supported under this AO must contribute to the achievement of the following objective:

4. Applications

4.1 Required Documentation

To satisfy CSA requirements, the application must include the following:

It is the applicant's responsibility to ensure that the application complies with all relevant Canadian legislation and bylaws (federal, provincial/territorial and municipal). Applications sent by email shall not be accepted and incomplete applications shall not be considered.

Applications must be mailed to the CSA at the following address:

Bed-Rest and Isolation Studies AO
c/o Perry Johnson-Green
Canadian Space Agency
6767 Route de l'Aéroport
Saint-Hubert, Quebec J3Y 8Y9

4.2 Service Standards – Complete Applications

Applicants will be notified in writing of decisions regarding their application. Applications that have been selected will be announced on the CSA website on the page for this AO.

The CSA has set service standards related to delays in processing requests, the acknowledgement of receipt, funding decision and payment processes.

Acknowledgement: The CSA's goal is to acknowledge receipt of proposals within 2 weeks of receiving a completed application package.

Decision: The CSA's goal is to respond to the proposal within 10 weeks of receiving a completed application package or closing date of the AO, and to send for signature a grant agreement within 18 weeks after formal approval of the proposal.

Payment:
Grant: The CSA's goal is to issue payments within 4 weeks of the successful fulfillment of requirements outlined in the grant agreement.

Compliance with these service standards is a shared responsibility. The applicant must submit all required documentation in a timely fashion. Service standards may vary by AO.

5. Evaluation

5.1 Eligibility Criteria

5.2 Evaluation Criteria

An evaluation committee will assess screened-in applications according to the criteria described below. The eligible projects to be evaluated in this AO will have already been evaluated for scientific merit and feasibility through the ESA AO processes; therefore the CSA will focus its evaluation on the following criteria.

5.2.1 Mandatory Criteria

Each submission will first be evaluated to ensure it meets the mandatory criteria.

5.2.1.1. Eligibility of the applicant

Description: This criterion evaluates whether the application has been submitted from an eligible recipient.

Scoring

Definition : The organization is an eligible recipient for a grant as described in Section 3.1 of this AO. (Scoring: Pass)

Definition : The organization is not an eligible recipient for a grant as described in Section 3.1 of this AO. (Scoring: Fail)

5.2.1.2. Eligibility of the project

Description: This criterion evaluates whether the application is an eligible project for this AO.

Scoring

Definition : The project is eligible for a grant as described in Section 3.2 of this AO. (Scoring: Pass)

Definition : The project is not eligible for a grant as described in Section 3.2 of this AO. (Scoring: Fail)

5.2.1.3. Alignment with priorities of the G&C Program

Description: This criterion evaluates how the project will contribute to the Grant and contribution (G&C) Program objectives.

Scoring

Definition : The application clearly demonstrates how the project will help support the development of science and technology relevant to the priorities of the CSA, or support information gathering, studies and research related to space. (Scoring: Pass)

Definition : The application does not demonstrate how the project will help support the development of science and technology relevant to the priorities of the CSA, or support information gathering, studies and research related to space. (Scoring: Fail)

5.2.2 Graded Evaluation Criteria

Table 5.1 Summary Table of Graded Evaluation Criteria

Submissions will be evaluated using the following graded criteria. To be considered eligible for funding, they must receive a score greater than 125/200. These criteria and ratings are described in detail below.

Criteria Maximum points for evaluation Minimum points to pass Poor Average Good Excellent
Benefits to Canada /40
a) Alignment with the priorities of the CSA Space Life Sciences Program (see Table 3.1) 35 25 0 15 25 35
b) Potential of the work to inform Canadian healthcare practices 35 15 0 15 25 35
2. Project Feasibility, Resources and Risk Assessment /30
a) Budget and Resources Allocation 15 5 0 5 10 15
b) Risk Management 15 0 0 5 10 15
3. Results "Scientific Merit Review": Significance, Approach, Innovation, Personnel, Environment (as assessed by the ESA peer review evaluation process). 100 80 (ESA Scientific Merit Review Score)
Total 200 125Table D-1 Note 1

Graded Criterion 1. Benefits to Canada

a) Alignment with the priorities of the CSA Space Life Sciences Program

Description: This criterion evaluates whether the proposed research project is aligned with the priorities of the CSA Space Life science program, which are to identify, understand, mitigate or eliminate health risks associated with human space flights, and to understand and address the needs of humans during those missions.

Maximum: 35
Minimum: 25

Poor: The research does not address a risk of human space flight as listed in Table 3.1. (Score: 0)

Average: One of the objectives addresses a risk of human space flight as described in Table 3.1, but overall, the proposal only indirectly addresses this risk. (Score: 15)

Good: One of the research objectives directly addresses a risk of human space flight as described in Table 3.1 (Score: 25)

Excellent: The proposed research as a whole is targeted to directly address one or more risks of human space flight as described in Table 3.1. The proposal as a whole addresses risks associated with human space flight. (Score: 35)

b) Potential of the work to inform Canadian healthcare practices

Description: This criterion evaluates the proposal's description of the potential of the research to contribute positively to Canada through reducing the costs of Canadian healthcare practices.

Maximum: 35
Minimum: 15

Poor: The research does not have any valid, foreseeable application to decreasing the costs of healthcare in Canada, or the description is lacking. (Score: 0)

Average: A description is provided where the research has valid, foreseeable application to decreasing the costs of healthcare in Canada. After the proposed research, further research using bed-rest or isolation facilities will be required before benefits to the healthcare system can be realized. (Score: 15)

Good: The description includes a valid, foreseeable application of the research to decreasing the costs of healthcare in Canada. After the proposed research, applied research (e.g. testing of protocols in non-bedrest or isolation contexts) will be required before benefits to the healthcare system can be realized. (Score: 25)

Excellent: The description includes a valid, foreseeable application of the research to decreasing the costs of healthcare in Canada. The results of the proposed research can logically be foreseen to be directly applied to decrease the costs of healthcare in Canada. (Score: 35)

Graded Criterion 2. Project Feasibility, Resources and Risk Assessment

a) Budget and Resources Allocation

Description: This criterion evaluates the adequacy of the budget and resources allocation to tasks, level of efforts and material resources. Applicants need to present an itemized budget describing project expenditures and sources of funding.

Note: Over-budgeting (i.e. padding) will be penalized, so applicants are encouraged to provide their best estimates of project costs.

Maximum: 15
Minimum: 5

Poor: The proposal presents an unclear or incomplete description of budget and resources allocation, or the description provided shows inadequate budget and resources allocation or insufficient and/or inadequate justification of project expenditures. (Score: 0)

Average: The budget and resources allocation are presented; however, some information fails to provide a clear overall picture, or the justification of expenditure is incomplete. (Score: 5)

Good: Acceptable budget and allocation of resources. No problematic aspect. Resources allocation, level of effort appear adequate and logic. Project expenditures are adequately justified. (Score: 10)

Excellent: The budget and resource allocation is of superior quality; it is detailed and clear. Clever allocation of resources and level of efforts, with clear justification provided. (Score: 15)

b) Risk Management

Maximum: 15
Minimum: 0

Description: The proposal needs to expose project risk management and mitigation strategies. This criterion evaluates the knowledge of potential pitfalls and obstacles that may occur during project course and adequacy of proposed preventive/remedial measures. The proposal shall in particular address science-related risk and mitigation strategies related to the completion of the project they are presenting, as well as standard project management risks.

Poor: The proposal does not identify any key risks or mitigation strategies, or some risks are identified but related mitigation strategies are missing or inadequate. (Score: 0)

Average: Some, but not all, key risks and their mitigation strategies are defined. Some information is lacking. (Score: 5)

Good: Proposal shows general understanding of key risks and potential pitfalls during this type of project and proposes elements of preventive/remedial measures to ensure quality of results. (Score: 10)

Excellent: Proposal shows clear understanding of key risks and obstacles/pitfalls accompanied by clear and adequate discussion of preventive/remedial measures to ascertain quality results. Key risks and their mitigation strategies are well described. The risk evaluation occurrence probability is deemed realistic. (Score: 15)

Graded Criterion 3. Results

Scientific Merit Review (as assessed by the ESA peer review evaluation process):

Description: This criterion will use the ESA Scientific Merit Review score, which assessed the Study Significance, Approach, Innovation, Personnel, and Institutional Environment.

5.3 Evaluation Process

Only applications that have passed the eligibility criteria listed in Section 3 will be considered further.

Several evaluators could assess each application based on evaluation criteria listed in Section 5. Before a final decision is made, Program Managers may seek input and advice from others, including, but not limited to, federal, provincial/territorial and municipal government agencies, organizations, etc.

The determination of the amount of support will take into consideration CSA availability of funds, the total cost of the project as well as the other confirmed sources of funds invested by other stakeholders and the applicant.

All proposals from bed-rest and isolation studies will be placed in one pool. Proposals will be ranked on the basis of a numerical average of the scores obtained in this CSA competition, and the scores obtained in the ESA peer review.

6. Funding

6.1 Available Funding

The total financing amount given in grant for this AO is $1.5 million for a maximum period of three years. It is expected that funding for bed-rest initiatives will cover a maximum period of two years, and a maximum of three years for studies conducted at the Concordia Antarctic Station. The overall number of grants awarded and their level will depend on the budget requested by each proposal and the availability of funds.

The CSA reserves the right not to accept any proposals or to reduce the amount of the grant requested at its entire discretion.

Approved proposals will be eligible for total government (federal, provincial/territorial and municipal) assistance of up to 100% of total project costs.

Applicants are required to identify all sources of funding in their application and to confirm this information in a funding agreement if the project is selected for funding. In addition, upon completion of a project, the applicant will be required to disclose all sources of funding. To determine the amount of financial support it will offer, the CSA will consider the total project cost and funding from other stakeholders and the applicant.

6.2 Eligible Costs

Eligible costs are direct expenses associated with the delivery of the approved project that is required to achieve the results of the project. Expenses will be covered subject to the applicant signing a funding agreement, in the form of a grant, with the CSA.

Applicants to this CSA AO cannot include as eligible costs any costs related to non-Canadian Co-Investigators or non-Canadian Principal Investigators or their work within the proposal. These costs should be submitted to the appropriate national agency for funding.

Grants

The eligible costs for grants under this AO are the following:

Costs related to the bed-rest facility and subjects are covered by ESA. Some transportation fees for Concordia isolation studies are covered by ESA or third parties, and would therefore not be covered in the CSA funding agreements.

7. Funding Agreements

7.1 Payments

The CSA and the successful applicants (the recipients) will sign a funding agreement. This represents a condition for any payment made by the CSA with respect to the approved project.

For grant agreements, payments will be made in a lump sum or in instalments as described in the signed agreement. Grant funding agreements will include a clause stipulating the obligation for the recipients to confirm, once a year in the case of multi-year agreements, their eligibility to this Program Component and to inform the CSA in writing of any changes to the conditions used in determining their entitlement and eligibility to this Component.

7.2 Conflict of Interest

In the funding agreement, the recipient will certify that any former public office holder or public servant it employs complies with the provisions of the relevant Conflict of Interest and Post-Employment Code for Public Office Holders and the Value and Ethics Code for the Public Sector respectively.

7.3 Intellectual Property

Applicants to this AO should be aware that the ESA Data Policy applies to their project selected either from the ESA AO for Life Science Research Using the Spaceflight Analogue "Bed Rest" (AO-13-BR) or the ESA Call for Medical, Physiological and Psychological Research Using Concordia Antarctic Station as Human Exploration Analogue (AO-13-Concordia). The projects funded through this AO will be conducted during campaigns organized by ESA, and therefore the ESA Data Policy (quoted in ESA's AO documents) has precedence over the other conditions of Intellectual Property stated below.

The CSA funding agreement establishes that all intellectual property developed by the recipient in the course of the project shall vest in the recipient. When applicable, the funding agreement will include a provision granting to the CSA a non-exclusive, irrevocable, world-wide, free and royalty-free licence in perpetuity to use or sub-licence the use of any such Intellectual Property contained in recipient reports for non-commercial governmental purposes.

7.4 Organizations in Quebec

An organization in Quebec whose operations are partially or fully funded by the province of Quebec may be subject to An Act Respecting the Ministère du Conseil exécutif, R.S.Q., Chapter M-30.

Under Sections 3.11 and 3.12 of An Act Respecting the Ministère du Conseil exécutif, R.S.Q., Chapter  M-30 (hereinafter referred to as the Act), certain entities/organizations, as defined in the meaning of the Act, such as municipal bodies, school bodies or public agencies, must obtain an authorization from the Secrétariat aux affaires intergouvernementales canadiennes du Québec (SAIC), as indicated by the Act, before signing any funding agreement with the Government of Canada, its departments or agencies, or a federal public agency.

Consequently, any entity that is subject to the Act is responsible for obtaining such authorization before signing any funding agreement with the Government of Canada.

Applicants from Quebec must complete, sign and include the M-30 Supporting Documentation form with their application.

7.5 Performance Measurement

The CSA will ask the recipients to report on certain elements of projects such as:

Knowledge

Capacity

Collaboration

As a courtesy, the CSA would like to receive a copy of publications arising from the work and to be informed in advance of significant press releases or media interest resulting from the work.

7.6 Audit

The recipient of a funding agreement shall keep proper records of all documentation related to the funded project, for the duration of the project and for six (6) years after the completion date of the project, in the event of an audit. This documentation shall be available upon request.

8. Privacy Notice Statement

The CSA will comply with the federal Access to Information Act and Privacy Act with respect to applications received under this Component. By submitting your personal information, you are consenting to its collection, use and disclosure in accordance with the following Privacy Notice Statement, which explains how the applicant's information will be managed.

Necessary measures have been taken to protect the confidentiality of the information provided by the applicant. This information is collected under the authority of the CSA Class Grant and Contribution Program to Support Research, Awareness and Learning in Space Science and Technology – Research Component, and will be used for the evaluation and selection of proposals. Personal information (such as contact information and biographical information) included in the rejected proposals will be stored in a Personal Information CSA Bank for five years and then destroyed (Personal Information File no. ASC PPU045). Personal information included in the successful proposals will be retained along with the proposal results for historical purposes. These data are protected under the Privacy Act. According to the Privacy Act, the data linked to one individual and included in the proposal being evaluated can be accessed by the specific concerned individual who has rights with respect to this information. This individual may, upon request, (1) be given access to his/her data and (2) have incorrect information corrected or have a notation attached.

Applicants should note that for all agreements over $25,000, information related to the funding agreement (amount, grant, name of the recipient and project location) through this Component and the purpose of the funding will be made available to the public on the CSA website.

If you need additional information on privacy matters before sending your proposal, contact Danielle Bourgie, Coordinator, Access to Information and Privacy, at the CSA.

Telephone: 450-926-4866
Email: aiprp-atip@asc-csa.gc.ca

9. Frequently Asked Questions (FAQ)

It is the responsibility of the applicants to obtain clarification of the requirements contained herein, if necessary, before submitting an application. At any point of the process, applicants are welcome to share with the CSA their comments or suggestions regarding the AO, the program or the process.

However, during the course of a competitive AO, for reasons of fairness to all competitors, the CSA cannot provide specific information directly to a company or someone about a potential proposal or any other subjects.

Applicants can also use the generic web-based Comments and Suggestions Box available at www.asc-csa.gc.ca/eng/funding-programs/grants-and-contributions-snapshot.asp#comments.

For any questions related to the AO, applicants can either use the web-based Comments and Suggestion Box or email address (lecedessetc-thegandccoe@asc-csa.gc.ca); both tools are anonymous. The questions and answers related to this AO will be posted on the CSA website in the Frequently Asked Questions section of this AO. The CSA will respond to questions received before November 28, 2014, at 4:00 p.m. (EST).

Question 1: The AO states that $1.5 million over 3 years is available in the grant. Is this the maximum amount per project or is it the total amount for all projects?

Answer 1: The total amount of funds available for all projects is $1.5 million.

Question 2: Do you require original signatures within the application, or can they be electronic?

Answer 2: Section 3 of the application form requires original signatures from the Canadian PI or Co-I (note that Co-I signature is only required if a Co-I on a non-Canadian-led proposal is independently requesting research support through this competition), and the duly authorized representative from the organization. These are the only original signatures required.

Question 3: In Section 4 of the application form (Evaluation Criteria), applicants are required to describe and justify how their proposal meets the Mandatory Criteria and the Graded Evaluation Criteria. How does the 300 word limit apply?

Answer 3: In section 4 of the application form, applicants have a 300 word limit for each criterion to describe and justify how the proposal meets this individual criterion.

Question 4: Non-Canadian investigators are not eligible for costs related to their work within the proposal. Should they be listed as a Team Member in Section 6 of the Application Form?

Answer 4: All team members, whether Canadian or international, must be listed in Section 6 of the Application Form, regardless of their affiliation.

Question 5: Is there a contact who we can call to discuss details of the application?

Answer 5: As indicated in the AO, questions shall be addressed to lecedessetc-thegandccoe@asc-csa.gc.ca email address. To ensure a fair and transparent process, the questions and answers related to this AO will be posted on the CSA website in the Frequently Asked Questions section of this AO where they are accessible to all applicants.

Question 6: I will be traveling during most of the posting period of this AO and it may be impossible for me to submit my application by the current deadline, especially due to the challenge of gathering signatures from the relevant administrators or their replacements. I would like to request an extension to December 15 in order to complete the proposal and obtain the necessary approvals.

Answer 6: The only original signatures required are those of Section 3 of the application form from the Canadian PI or Co-I, and the duly authorized representative from the organization.

The evaluation process will begin soon after the AO closes, and extending the AO posting up to December 15 puts the evaluation schedule at risk and delays funding of successful proposals. However, a change of deadline from November 21 to December 5 is acceptable.

Question 7: The AO says that the application package must be received at the CSA no later than 16:00 EST on November 21, 2014. There are few methods of delivery that can guarantee reception at the CSA before the deadline. Would the CSA please change the deadline from a "received by" deadline to a "mailed by" deadline?

Answer 7: To ensure fairness to all applicants across Canada and keep to our reviewing schedule, we will accept original applications that are mailed by the deadline, as long as the electronic version of the corresponding application is received by the "received by" deadline, at lecedessetc-thegandccoe@asc-csa.gc.ca. The applicant may encrypt his/her email, in which case CSA will phone him/her for the decryption password.

Question 8: There is a possibility of running the study I plan to propose at both the ESA facility and another facility. This presents several advantages: increasing the subject pool and allowing comparisons on some additional variables. Can the CSA AO accommodate this?

Answer 8: Projects eligible for funding in this solicitation process are those where Canadian researchers have been selected through one of the ESA AOs to conduct a life sciences experiment during ESA bed-rest campaigns or Concordia Antarctic Station studies. The funding obtained through this competition must be used to support and strengthen the study's expected outcomes.

Date modified: